HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monica Giovannini Selected Research

capmatinib

1/2021Pharmacokinetics and safety of capmatinib with food in patients with MET-dysregulated advanced solid tumors.
1/2021Effect of capmatinib on the pharmacokinetics of digoxin and rosuvastatin administered as a 2-drug cocktail in patients with MET-dysregulated advanced solid tumours: A phase I, multicentre, open-label, single-sequence drug-drug interaction study.
2/2020Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts.
1/2020Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Monica Giovannini Research Topics

Disease

9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2009
8Neoplasms (Cancer)
01/2021 - 12/2003
4Breast Neoplasms (Breast Cancer)
10/2010 - 12/2002
2Colorectal Neoplasms (Colorectal Cancer)
02/2020 - 01/2009
2Carcinoma (Carcinomatosis)
05/2013 - 12/2011
1Neuroendocrine Carcinoma
05/2013
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2013
1Mitochondrial Myopathies (Mitochondrial Myopathy)
08/2012
1Neoplasm Metastasis (Metastasis)
09/2009
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2009
1Lung Neoplasms (Lung Cancer)
06/2008
1Mammary Paget's Disease
08/2006
1Neoplasm Micrometastasis
12/2003

Drug/Important Bio-Agent (IBA)

4capmatinibIBA
01/2021 - 01/2020
3ErbB Receptors (EGF Receptor)IBA
11/2011 - 06/2008
2Tyrosine Kinase InhibitorsIBA
01/2022 - 11/2011
2Estrogen ReceptorsIBA
06/2008 - 12/2003
2Biological ProductsIBA
09/2006 - 12/2003
1nazartinibIBA
01/2022
1TabletsIBA
01/2021
1Antineoplastic Agents (Antineoplastics)IBA
01/2021
1Capsules (Microcapsules)IBA
02/2020
1Temozolomide (Temodar)FDA LinkGeneric
05/2013
1Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2013
1GemcitabineFDA Link
05/2013
1Cisplatin (Platino)FDA LinkGeneric
05/2013
1Etoposide (VP 16)FDA LinkGeneric
05/2013
1VaccinesIBA
09/2012
1Gefitinib (Iressa)FDA Link
12/2011
1Angiogenesis InhibitorsIBA
10/2010
1Immunomodulating AgentsIBA
01/2010
1ProMune (CpG 7909)IBA
01/2010
1Lenalidomide (CC 5013)FDA Link
01/2010
1Monoclonal AntibodiesIBA
01/2009
1Progesterone Receptors (Progesterone Receptor)IBA
12/2003
1Laminin ReceptorsIBA
12/2003
1Laminin (Merosin)IBA
12/2003
1Glycoproteins (Glycoprotein)IBA
12/2003
1ThymidineIBA
12/2002

Therapy/Procedure

7Therapeutics
01/2022 - 06/2008
4Drug Therapy (Chemotherapy)
05/2013 - 09/2009
2Mastectomy (Mammectomy)
09/2006 - 08/2006
1Radiotherapy
01/2010
1Neoadjuvant Therapy
09/2009
1Simple Mastectomy
08/2006